JILUNAR
LIVE

Serial Number

79186612

Owner

NOVARTIS AG

Filing Date

Feb 19, 2016

Add to watchlist:

No watchlists yet
View on USPTO

JILUNAR Trademark

Serial Number: 79186612 • Registration: 5033991

JILUNAR is a trademark filed by NOVARTIS AG on February 19, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,172 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 19, 2016

Registration Date

September 6, 2016

Published for Opposition

June 21, 2016

Cancellation Date

April 22, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 15, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 15, 2019 DETH
NOTIFICATION PROCESSED BY IB
Jul 21, 2017 GPNX
NOTIFICATION PROCESSED BY IB
Feb 10, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Oct 13, 2016 FICS
FINAL DISPOSITION PROCESSED
Oct 13, 2016 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Oct 6, 2016 GPAR
REGISTERED-PRINCIPAL REGISTER
Sep 6, 2016 R.PR
PUBLISHED FOR OPPOSITION
Jun 21, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 1, 2016 OP2R
NOTICE OF PUBLICATION
Jun 1, 2016 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2016 CNSA
APPLICATION FILING RECEIPT MAILED
May 13, 2016 MAFR
ASSIGNED TO EXAMINER
May 9, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 6, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 5, 2016 SDRC